Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study

ABSTRACT: Background and aims. Background and aims. Heter Background and aims. ogeneous data has been reported regarding liver transplantation (LT) for hepatocellular carcinoma (HCC) in Latin America. We aimed to describe treatment during waiting list, survival and recurrence of HCC after LT in a mu...

Full description

Autores:
Piñero Fernández, Federico
Boteon, Yuri Longatto
Hoyos Duque, Sergio Iván
Marciano, Sebastián
Anders, María Margarita
Varón Puerta, Adriana
Zerega, Alina Raquel
Poniachik Teller, Jaime Melchor
Soza Ried, Alejandro
Padilla Machaca, Martín
Menéndez, Josemaría
Zapata Larraín, Rodrigo
Vilatoba Chapa, Mario
Muñoz Espinosa, Linda Elsa
Maraschio, Martín Alejandro
Fauda, Martín
McCormack, Lucas
Gadano, Adrián Carlos
Boin, Ilka de Fatima
Parente García, José Huygens
Silva, Marcelo Oscar
Costa, Paulo Cesar
Tipo de recurso:
Article of investigation
Fecha de publicación:
2018
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/25893
Acceso en línea:
http://hdl.handle.net/10495/25893
Palabra clave:
Neoplasias Hepáticas
Liver Neoplasms
Trasplante de Hígado
Liver Transplantation
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_c0cf527f7aa63350db98e1a284ee9fdf
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/25893
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
title Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
spellingShingle Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
Neoplasias Hepáticas
Liver Neoplasms
Trasplante de Hígado
Liver Transplantation
title_short Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
title_full Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
title_fullStr Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
title_full_unstemmed Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
title_sort Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort Study
dc.creator.fl_str_mv Piñero Fernández, Federico
Boteon, Yuri Longatto
Hoyos Duque, Sergio Iván
Marciano, Sebastián
Anders, María Margarita
Varón Puerta, Adriana
Zerega, Alina Raquel
Poniachik Teller, Jaime Melchor
Soza Ried, Alejandro
Padilla Machaca, Martín
Menéndez, Josemaría
Zapata Larraín, Rodrigo
Vilatoba Chapa, Mario
Muñoz Espinosa, Linda Elsa
Maraschio, Martín Alejandro
Fauda, Martín
McCormack, Lucas
Gadano, Adrián Carlos
Boin, Ilka de Fatima
Parente García, José Huygens
Silva, Marcelo Oscar
Costa, Paulo Cesar
dc.contributor.author.none.fl_str_mv Piñero Fernández, Federico
Boteon, Yuri Longatto
Hoyos Duque, Sergio Iván
Marciano, Sebastián
Anders, María Margarita
Varón Puerta, Adriana
Zerega, Alina Raquel
Poniachik Teller, Jaime Melchor
Soza Ried, Alejandro
Padilla Machaca, Martín
Menéndez, Josemaría
Zapata Larraín, Rodrigo
Vilatoba Chapa, Mario
Muñoz Espinosa, Linda Elsa
Maraschio, Martín Alejandro
Fauda, Martín
McCormack, Lucas
Gadano, Adrián Carlos
Boin, Ilka de Fatima
Parente García, José Huygens
Silva, Marcelo Oscar
Costa, Paulo Cesar
dc.subject.decs.none.fl_str_mv Neoplasias Hepáticas
Liver Neoplasms
Trasplante de Hígado
Liver Transplantation
topic Neoplasias Hepáticas
Liver Neoplasms
Trasplante de Hígado
Liver Transplantation
description ABSTRACT: Background and aims. Background and aims. Heter Background and aims. ogeneous data has been reported regarding liver transplantation (LT) for hepatocellular carcinoma (HCC) in Latin America. We aimed to describe treatment during waiting list, survival and recurrence of HCC after LT in a multicenter study from Latin America. Material and methods. Material and methods. Patients with Material and methods. HCC diagnosed prior to transplant (cHCC) and incidentally found in the explanted liver (iHCC) were included. Imaging-explanted features were compared in cHCC (non-discordant if pre and post-LT were within Milan, discordant if pre-LT was within and post-LT exceeding Milan). Results. Overall, Results.Results. 435 patients with cHCC and 92 with iHCC were included. At listing, 81% and 91% of cHCC patients were within Milan and San Francisco criteria (UCSF), respectively. Five-year survival and recurrence rates for cHCC within Milan, exceeding Milan/within UCSF and beyond UCSF were 71% and 16%; 66% and 26%; 46% and 55%, respectively. Locoregional treatment prior to LT was performed in 39% of cHCC within Milan, in 53% beyond Milan/within UCSF and in 83% exceeding UCSF (p < 0.0001). This treatment difference was not observed according to AFP values (d100, 44%; 101-1,000, 39%, and > 1,000 ng/mL 64%; p = 0.12). Discordant imaging-explanted data was observed in 29% of cHCC, showing lower survival HR 2.02 (CI 1.29; 3.15) and higher recurrence rates HR 2.34 when compared to AFP <100 ng/mL. Serum AFP > 1,000 ng/mL at listing was independently associated with a higher 5-year recurrence rate and a HR of 3.24 when compared to AFP <100 ng/mL. Conclusion. Although overall r Conclusion.Conclusion. esults are comparable to other regions worldwide, preLT treatment not only considering imaging data but also AFP values should be contemplated during the next years.
publishDate 2018
dc.date.issued.none.fl_str_mv 2018
dc.date.accessioned.none.fl_str_mv 2022-02-08T21:41:09Z
dc.date.available.none.fl_str_mv 2022-02-08T21:41:09Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 1665-2681
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/25893
dc.identifier.doi.none.fl_str_mv 10.5604/01.3001.0010.8648
identifier_str_mv 1665-2681
10.5604/01.3001.0010.8648
url http://hdl.handle.net/10495/25893
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Ann Hepatol
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 12
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Fundación Clínica Médica Sur
dc.publisher.group.spa.fl_str_mv Grupo de Gastrohepatología
dc.publisher.place.spa.fl_str_mv Ciudad de México, México
institution Universidad de Antioquia
bitstream.url.fl_str_mv http://bibliotecadigital.udea.edu.co/bitstream/10495/25893/1/HoyosSergio_2018_LiverCarcinomaLatinAmerican.pdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/25893/2/license_rdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/25893/3/license.txt
bitstream.checksum.fl_str_mv a3de2a9dc2e6e1db185a3363d4d4ed1f
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1812173252122902528
spelling Piñero Fernández, FedericoBoteon, Yuri LongattoHoyos Duque, Sergio IvánMarciano, SebastiánAnders, María MargaritaVarón Puerta, AdrianaZerega, Alina RaquelPoniachik Teller, Jaime MelchorSoza Ried, AlejandroPadilla Machaca, MartínMenéndez, JosemaríaZapata Larraín, RodrigoVilatoba Chapa, MarioMuñoz Espinosa, Linda ElsaMaraschio, Martín AlejandroFauda, MartínMcCormack, LucasGadano, Adrián CarlosBoin, Ilka de FatimaParente García, José HuygensSilva, Marcelo OscarCosta, Paulo Cesar2022-02-08T21:41:09Z2022-02-08T21:41:09Z20181665-2681http://hdl.handle.net/10495/2589310.5604/01.3001.0010.8648ABSTRACT: Background and aims. Background and aims. Heter Background and aims. ogeneous data has been reported regarding liver transplantation (LT) for hepatocellular carcinoma (HCC) in Latin America. We aimed to describe treatment during waiting list, survival and recurrence of HCC after LT in a multicenter study from Latin America. Material and methods. Material and methods. Patients with Material and methods. HCC diagnosed prior to transplant (cHCC) and incidentally found in the explanted liver (iHCC) were included. Imaging-explanted features were compared in cHCC (non-discordant if pre and post-LT were within Milan, discordant if pre-LT was within and post-LT exceeding Milan). Results. Overall, Results.Results. 435 patients with cHCC and 92 with iHCC were included. At listing, 81% and 91% of cHCC patients were within Milan and San Francisco criteria (UCSF), respectively. Five-year survival and recurrence rates for cHCC within Milan, exceeding Milan/within UCSF and beyond UCSF were 71% and 16%; 66% and 26%; 46% and 55%, respectively. Locoregional treatment prior to LT was performed in 39% of cHCC within Milan, in 53% beyond Milan/within UCSF and in 83% exceeding UCSF (p < 0.0001). This treatment difference was not observed according to AFP values (d100, 44%; 101-1,000, 39%, and > 1,000 ng/mL 64%; p = 0.12). Discordant imaging-explanted data was observed in 29% of cHCC, showing lower survival HR 2.02 (CI 1.29; 3.15) and higher recurrence rates HR 2.34 when compared to AFP <100 ng/mL. Serum AFP > 1,000 ng/mL at listing was independently associated with a higher 5-year recurrence rate and a HR of 3.24 when compared to AFP <100 ng/mL. Conclusion. Although overall r Conclusion.Conclusion. esults are comparable to other regions worldwide, preLT treatment not only considering imaging data but also AFP values should be contemplated during the next years.COL002415912application/pdfengFundación Clínica Médica SurGrupo de GastrohepatologíaCiudad de México, Méxicoinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Results of Liver Transplantation for Hepatocellular Carcinoma in a Multicenter Latin American Cohort StudyNeoplasias HepáticasLiver NeoplasmsTrasplante de HígadoLiver TransplantationAnn HepatolAnnals of Hepatology256267172ORIGINALHoyosSergio_2018_LiverCarcinomaLatinAmerican.pdfHoyosSergio_2018_LiverCarcinomaLatinAmerican.pdfArtículo de investigaciónapplication/pdf302547http://bibliotecadigital.udea.edu.co/bitstream/10495/25893/1/HoyosSergio_2018_LiverCarcinomaLatinAmerican.pdfa3de2a9dc2e6e1db185a3363d4d4ed1fMD51CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823http://bibliotecadigital.udea.edu.co/bitstream/10495/25893/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/25893/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD5310495/25893oai:bibliotecadigital.udea.edu.co:10495/258932022-02-08 16:41:10.499Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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